These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 3088432

  • 1. [Isolation and characteristics of urokinase-type plasminogen activator from a culture of human embryo lung fibroblasts].
    Shevelev AIa, Barshevskaia TN, Belogurov AA, Kratasiuk GA, Goriunova LE.
    Mol Biol (Mosk); 1986; 20(3):778-88. PubMed ID: 3088432
    [Abstract] [Full Text] [Related]

  • 2. Isolation and purification of plasminogen activator from Yoshida ascites Sarcoma of rats.
    Nulkar MW, Pawse AR.
    Indian J Biochem Biophys; 1991 Feb; 28(1):46-51. PubMed ID: 1905268
    [Abstract] [Full Text] [Related]

  • 3. Monoclonal antibodies against human high molecular weight urinary urokinase: application for affinity purification of urinary prourokinase.
    Wojta J, Kirchheimer JC, Turcu L, Christ G, Binder BR.
    Thromb Haemost; 1986 Jun 30; 55(3):347-51. PubMed ID: 3092391
    [Abstract] [Full Text] [Related]

  • 4. Monoclonal antibodies to human 54,000 molecular weight plasminogen activator inhibitor from fibrosarcoma cells--inhibitor neutralization and one-step affinity purification.
    Nielsen LS, Andreasen PA, Grøndahl-Hansen J, Huang JY, Kristensen P, Danø K.
    Thromb Haemost; 1986 Apr 30; 55(2):206-12. PubMed ID: 3520936
    [Abstract] [Full Text] [Related]

  • 5. Purification and characterization of single-chain urokinase-type plasminogen activator (pro-urokinase) from human A431 cells.
    Corti A, Nolli ML, Soffientini A, Cassani G.
    Thromb Haemost; 1986 Oct 21; 56(2):219-24. PubMed ID: 3101222
    [Abstract] [Full Text] [Related]

  • 6. Isolation and characterization of a urokinase-type plasminogen activator (Mr = 54,000) from cultured human endothelial cells indistinguishable from urinary urokinase.
    Booyse FM, Osikowicz G, Feder S, Scheinbuks J.
    J Biol Chem; 1984 Jun 10; 259(11):7198-205. PubMed ID: 6539333
    [Abstract] [Full Text] [Related]

  • 7. Recovery of urokinase from integrated mammalian cell culture cryogel bioreactor and purification of the enzyme using p-aminobenzamidine affinity chromatography.
    Bansal V, Roychoudhury PK, Mattiasson B, Kumar A.
    J Mol Recognit; 2006 Jun 10; 19(4):332-9. PubMed ID: 16761300
    [Abstract] [Full Text] [Related]

  • 8. Purification and characterization of single-chain urokinase-type plasminogen activator from human cell cultures.
    Stump DC, Lijnen HR, Collen D.
    J Biol Chem; 1986 Jan 25; 261(3):1274-8. PubMed ID: 3080423
    [Abstract] [Full Text] [Related]

  • 9. Molecular species of plasminogen activators secreted by normal and neoplastic human cells.
    Wilson EL, Becker ML, Hoal EG, Dowdle EB.
    Cancer Res; 1980 Mar 25; 40(3):933-8. PubMed ID: 7193517
    [Abstract] [Full Text] [Related]

  • 10. Physicochemical properties of highly purified kidney cultured plasminogen activator (single chain urokinase).
    Sumi H, Kosugi T, Matsuo O, Mihara H.
    Nihon Ketsueki Gakkai Zasshi; 1982 Feb 25; 45(1):119-28. PubMed ID: 7051725
    [No Abstract] [Full Text] [Related]

  • 11. Partial purification and characterization of native plasminogen activators from bovine milk.
    Deharveng G, Nielsen SS.
    J Dairy Sci; 1991 Jul 25; 74(7):2060-72. PubMed ID: 1894805
    [Abstract] [Full Text] [Related]

  • 12. Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins.
    Toki N, Sumi H, Sasaki K, Boreisha I, Robbins KC.
    J Clin Invest; 1985 Apr 25; 75(4):1212-22. PubMed ID: 3921568
    [Abstract] [Full Text] [Related]

  • 13. Plasminogen-activator in human early milk: its partial purification and characterization.
    Okamoto U, Horie N, Nagamatsu Y, Yamamoto JI.
    Thromb Haemost; 1981 Apr 30; 45(2):121-6. PubMed ID: 7196095
    [Abstract] [Full Text] [Related]

  • 14. Supermacroporous cryogel matrix for integrated protein isolation. Immobilized metal affinity chromatographic purification of urokinase from cell culture broth of a human kidney cell line.
    Kumar A, Bansal V, Andersson J, Roychoudhury PK, Mattiasson B.
    J Chromatogr A; 2006 Jan 20; 1103(1):35-42. PubMed ID: 16368104
    [Abstract] [Full Text] [Related]

  • 15. Purification of a specific placental plasminogen activator inhibitor by monoclonal antibody and its complex formation with plasminogen activator.
    Astedt B, Lecander I, Brodin T, Lundblad A, Löw K.
    Thromb Haemost; 1985 Feb 18; 53(1):122-5. PubMed ID: 3922076
    [Abstract] [Full Text] [Related]

  • 16. Rapid isolation of high molecular weight urokinase from native human urine.
    Huber K, Kirchheimer J, Binder BR.
    Thromb Haemost; 1982 Jun 28; 47(3):197-202. PubMed ID: 7051408
    [Abstract] [Full Text] [Related]

  • 17. Identification of subpopulations of human urinary plasminogen activators.
    Hart DA, Kramer R, Cieplak W.
    Thromb Haemost; 1984 Apr 30; 51(2):212-6. PubMed ID: 6539958
    [Abstract] [Full Text] [Related]

  • 18. Human synovial fibroblasts produce urokinase-type plasminogen activator.
    Medcalf RL, Hamilton JA.
    Arthritis Rheum; 1986 Nov 30; 29(11):1397-401. PubMed ID: 3096341
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Immunological characterization of plasminogen activator activities in human tissues and body fluids.
    Rijken DC, Wijngaards G, Welbergen J.
    J Lab Clin Med; 1981 Apr 30; 97(4):477-86. PubMed ID: 6782183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.